This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.
It is no longer the current profile. Read the canonical profile and its correction notice.
Update · July 27, 2026
We rewrote the profile summary to describe the cited study record more directly. The cited source and status did not change. 1
What this version reported
ClinicalTrials.gov lists a Roche-sponsored combination study as not yet recruiting, updated July 7, 2026.↗
Organizations named in cited records:
- Hoffmann-La Roche↗
Trial records: NCT07589686
Sources for this version
- 1Petrelintide With Enicepatide in Adults With Obesity or Overweight · record history version 3 · last update posted 2026-07-07 ↗
ClinicalTrials.gov · Official source · Source checked July 22, 2026